In this section you will find Selcia news and up-coming events Selcia is attending.
News & Events
Selcia appoints Simon Saxby as its Chief Executive Officer (CEO). He will assume his position in April and takes over from Dr Hans Fliri who retains his role as Chairman of the Board.
Selcia Limited is pleased to announce that its radiochemistry facility has been granted a Good Manufacturing Practice (GMP) certificate for the preparation of C-14 labeled Active Pharmaceutical Ingredients (APIs)
Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead’s liver disease research programmes.
Convergence Pharmaceuticals Limited, the new company focused on the development of novel and high value analgesic medicines, and Selcia Limited, today are pleased to announce that they have entered into a drug discovery collaboration
Selcia Limited today announced the high profile appointment of Simon Saxby to the Board as a non-executive director.